SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company Release: Cardiovascular Outcome Study on Tradjenta® (Linagliptin) Tablets in Adult Patients With Type 2 Diabetes Completes Enrollment